It influences serotonin metabolism, relevant to both mood and pain processing
Therefore, recent guidelines recommend GLP-1 RAs for patients with T2DM, established or high-risk atherosclerotic cardiovascular disease, and/or chronic kidney disease for glycemic management and comprehensive cardiovascular risk reduction [6,7]
Others use continuously at maintenance doses
Technology appraisal guidance TA664
GHK-Cu is a natural copper-binding peptide complex consisting of the tripeptide glycyl-L-histidyl-L-lysine bound to copper
Plated cells were pretreated with 4 L of agonist, or antagonist (Ex 9-39 (GLP-1R antagonist) or BIIE0246 (Y2-R antagonist)), at a given target concentration and incubated for 20 min before performing the assay